Alphabetâs medical arm Verily Life Sciences LLC is getting a major influx of cash from a Singapore investment company, boosting the odds of taking their futuristic approach to healthcare into Asian markets. Temasek Holdings Pte Ltd, a state-owned firm with US$415.8 billion in assets, is investing $800 million in Verily, according to a statement from the company Thursday. In exchange, Temasek will get a minority stake in Verily and a seat on its operating board.